Bridge to Industry
A lecture series fostering collaboration between academia and industry. The Faculty of Biology is proud to present a series of meetings focused on groundbreaking research and innovation in Israel’s life sciences industry.
Join us as leading researchers and entrepreneurs discuss challenges and solutions, fostering a dynamic community for:
- Enhanced Collaboration between academia and industry
- Building a Thriving Innovation Ecosystem with researchers, entrepreneurs, and students
- Advancing Applied Knowledge and breakthrough technologies in biotechnology
## Lecture 1: Pluri – Beyond Birth: Exploring Placental Potential in Biomedical Innovation
Speaker: Dr. Arthur Machlenkin, CSO of Pluri
Abstract:
Pluri, an Israeli clinical-stage company, is pioneering the development of innovative cell products derived from the placenta. This study investigates the potential of Placenta eXpanded (PLX) mesenchymal-like stromal cells for regenerative medicine applications. Characterized by their unique secretome, PLX cells possess distinct immunomodulatory and regenerative capabilities, making them promising candidates for therapeutic interventions. Specifically, this research delves into the therapeutic potential of PLX cells in treating acute radiation syndrome (ARS), capitalizing on their allogeneic nature and support for hematopoietic recovery. Additionally, Pluri explores the placenta as a source of non-conventional immune cells, which can be genetically modified to confer specificity against cancer antigens, thereby enhancing the efficacy of allogeneic immunotherapy of cancer. By concurrently investigating these avenues, this study aims to unlock the full therapeutic potential of placenta-derived cells, presenting innovative strategies for both regenerative medicine and cancer treatment.
Don’t miss this opportunity to connect and inspire!
